医学
心脏毒性
心脏毒性
重症监护医学
心力衰竭
模式
内科学
肿瘤科
毒性
社会科学
社会学
作者
Massimiliano Camilli,Daniela Cardinale,Patrizia Pedrotti,F. Turazza,Nadia Aspromonte,Maria Laura Canale,Irma Bisceglia,Fabrizio Oliva,Furio Colivicchi
出处
期刊:Future Cardiology
[Future Medicine]
日期:2022-09-01
标识
DOI:10.2217/fca-2022-0063
摘要
Overview of the meeting The Cardio-Oncology Symposium at the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Annual Meeting mainly focused on the diagnosis, management and prevention of cardiovascular toxicity of cancer drugs, in particular, cardiac dysfunction induced by anthracyclines. Although a variety of cardiac biomarkers and imaging modalities are available, there remains no consensus regarding their appropriate use to identify early and late cardiotoxicity and to guide preventive strategies. At the same time, the multitude of pharmacological trials, aimed at preventing cardiac damage through a neurohormonal blockade, provided conflicting results. Nevertheless, the advent of novel heart failure medications can change the decision-making of the cardio-oncologist. This symposium attempted to harmonize these issues.
科研通智能强力驱动
Strongly Powered by AbleSci AI